Repository blood samples will be used to study the association of circulating biomarkers with radiation therapy outcomes.
The purpose of this protocol is to create a repository of blood samples from patients diagnosed with primary and metastatic brain tumors who are being seen in the Department of Radiation Oncology at Duke Cancer Center.